Mutation screening of <it>ASMT</it>, the last enzyme of the melatonin pathway, in a large sample of patients with Intellectual Disability
<p>Abstract</p> <p>Background</p> <p>Intellectual disability (ID) is frequently associated with sleep disorders. Treatment with melatonin demonstrated efficacy, suggesting that, at least in a subgroup of patients, the endogenous melatonin level may not be sufficient to adequately set the sleep-wake...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2011-01-01
|
| Ráidu: | BMC Medical Genetics |
| Liŋkkat: | http://www.biomedcentral.com/1471-2350/12/17 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
